Ilse Treurnicht’s career spans scientific research, health and cleantech firms, venture and impact capital, and public policy. From 2005-2017 she served as CEO of MaRS in Toronto, a leading urban innovation hub.
Ilse was chair of the Canadian Task Force on Social Finance (2010). She was a member of Canada’s Advisory Council on Economic Growth and is on the Advisory Committee on Open Banking. She is executive chair of Triphase Accelerator Corporation (a cancer drug development firm), and chair of the Public Policy Forum. She holds a doctorate in chemistry from Oxford University, which she attended as a Rhodes Scholar.